Aster DM Healthcare Pre-IPO Review - Not Enough Information to Make an Investment Case
Aster DM Healthcare plans to raise up to US$300m through a sale of primary and secondary shares in India.Ā The bulk of the company's operationsĀ are...
326 Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as Indiaās biotechnology industry is projected to...
5k Views
India's Budgets: 2006-2015. Key Charts, and Key questions
In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: Ā 2014 Actual...
495 Views